Modeling of Cost Effectiveness of Pneumococcal Conjugate Vaccination Strategies in U.S. Older Adults

BACKGROUND: The 13-valent pneumococcal conjugate vaccine (PCV13) is approved by the U.S. Food and Drug Administration for adults, but its role in older adults is unclear. PURPOSE: To compare PCV13 strategies to currently recommended vaccination strategies in adults aged ≥65 years. METHODS: Using a M...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Smith, Kenneth J., Wateska, Angela R., Nowalk, Mary Patricia, Raymund, Mahlon, Lee, Bruce Y., Zimmerman, Richard K.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2013
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3601581/
https://ncbi.nlm.nih.gov/pubmed/23498103
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amepre.2012.11.035
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller